Oscar Health (NYSE:OSCR) Posts Earnings Results, Misses Expectations By $0.07 EPS

Oscar Health (NYSE:OSCR - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07), Zacks reports. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Oscar Health updated its FY 2025 guidance to EPS.

Oscar Health Trading Down 0.4 %

Shares of Oscar Health stock traded down $0.07 during trading on Friday, hitting $14.72. 4,028,930 shares of the company were exchanged, compared to its average volume of 3,870,337. The firm has a market capitalization of $3.64 billion, a P/E ratio of -735.38, a price-to-earnings-growth ratio of 0.50 and a beta of 1.73. The firm's fifty day moving average price is $15.09 and its 200 day moving average price is $16.83. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health has a 1-year low of $13.05 and a 1-year high of $23.79.

Insiders Place Their Bets

In other news, CAO Victoria Baltrus sold 8,078 shares of Oscar Health stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the sale, the chief accounting officer now directly owns 146,036 shares in the company, valued at $2,640,330.88. This trade represents a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Richard Scott Blackley sold 25,279 shares of the firm's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $457,044.32. Following the completion of the transaction, the chief financial officer now directly owns 881,841 shares of the company's stock, valued at approximately $15,943,685.28. This trade represents a 2.79 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have bought 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Company insiders own 25.11% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on OSCR shares. Bank of America lowered Oscar Health from a "neutral" rating to an "underperform" rating and decreased their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group assumed coverage on Oscar Health in a report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.